Roger N Gunn Selected Research

Roger N Gunn Research Topics

Disease

11	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 09/2010
9	Neuroinflammatory Diseases 01/2023 - 01/2011
8	Parkinson Disease (Parkinson's Disease) 01/2020 - 10/2015
7	Schizophrenia (Dementia Praecox) 06/2023 - 06/2009
7	Disease Progression 12/2020 - 01/2017
5	Cognitive Dysfunction 01/2022 - 09/2010
4	Inflammation (Inflammations) 01/2023 - 12/2016
3	Huntington Disease (Huntington's Disease) 01/2023 - 10/2015
3	Dementia (Dementias) 01/2021 - 08/2017
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 09/2016
3	Multiple Sclerosis 11/2017 - 07/2014
3	Neoplasms (Cancer) 06/2005 - 10/2002
2	Gliosis 01/2023 - 10/2019
2	Atrophy 01/2022 - 11/2017
2	Lung Diseases (Lung Disease) 12/2020 - 01/2017
2	Alcoholism (Alcohol Abuse) 01/2020 - 06/2014
2	Gambling (Pathological Gambling) 01/2020 - 11/2017
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019 - 01/2018
2	Major Depressive Disorder (Major Depressive Disorders) 01/2019 - 08/2013
2	Opioid-Related Disorders (Opiate Addiction) 11/2017 - 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2020
1	Cardiotoxicity 12/2019
1	Parkinsonian Disorders (Parkinsonism) 01/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Rheumatoid Arthritis 01/2018
1	Brain Injuries (Brain Injury) 01/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2017
1	Pneumonia (Pneumonitis) 12/2017
1	Neurobehavioral Manifestations 08/2017
1	Encephalitis (Encephalitis, Rasmussen) 12/2016
1	Spinal Cord Diseases 12/2016
1	Crohn Disease (Crohn's Disease) 11/2016
1	Substance-Related Disorders (Drug Abuse) 01/2016
1	Dyskinesias (Dyskinesia) 10/2015

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2014
8	Biomarkers (Surrogate Marker)IBA 10/2020 - 10/2002
7	Amyloid (Amyloid Fibrils)IBA 01/2022 - 09/2010
5	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 10/2019 - 10/2015
3	Glycoproteins (Glycoprotein)IBA 06/2023 - 01/2020
3	(methyl- (11)C)N- acetyl- N- (2- methoxybenzyl)- 2- phenoxy- 5- pyridinamineIBA 01/2023 - 12/2016
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2020 - 01/2017
3	LigandsIBA 01/2020 - 11/2017
3	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 03/2002
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 10/2019 - 01/2019
3	ThymidineIBA 06/2005 - 10/2002
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2010
2	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2020 - 01/2020
2	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 09/2002
2	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2020 - 01/2016
2	RolipramIBA 01/2020 - 08/2017
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2020 - 08/2017
2	SynucleinsIBA 10/2019 - 01/2019
2	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 05/2014
2	Levodopa (L Dopa)FDA LinkGeneric 08/2017 - 10/2015
1	Indicators and Reagents (Reagents)IBA 01/2023
1	laquinimodIBA 01/2023
1	tau Proteins (tau Protein)IBA 01/2023
1	Pyruvic Acid (Pyruvate)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2020
1	BromidesIBA 12/2019
1	triphenylphosphoniumIBA 12/2019
1	ethyleneIBA 12/2019
1	TriazolesIBA 12/2019
1	CationsIBA 12/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019
1	ImidazolinesIBA 10/2019
1	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 01/2019
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2019
1	neuromelaninIBA 01/2019
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Protein AggregatesIBA 03/2018
1	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 03/2018
1	Minocycline (Cyclops)FDA LinkGeneric 01/2018
1	Fibrinogen (Factor I)FDA Link 12/2017
1	GABA-A Receptors (GABA(A) Receptor)IBA 11/2017
1	FluorineIBA 11/2016
1	Huntingtin ProteinIBA 09/2016
1	Opioid Receptors (Opioid Receptor)IBA 01/2016
1	IMA107IBA 01/2016
1	Cocaine (Cocaine HCl)IBA 01/2016
1	3- benzenesulfonyl- 8- piperazin- 1- ylquinolineIBA 12/2015
1	GSK215083IBA 12/2015
1	EnzymesIBA 10/2015
1	Dopamine D3 ReceptorsIBA 06/2014
1	HeptanesIBA 08/2013
1	1- (3,4- dichlorophenyl)- 6- (methoxymethyl)- 4- azabicyclo(4.1.0)heptaneIBA 08/2013
1	Glycine Plasma Membrane Transport ProteinsIBA 12/2011
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 09/2010

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2019 - 10/2015
2	Therapeutics 01/2018 - 10/2015
1	Intravenous Administration 01/2022